ANGO - ANGIODYNAMICS INC

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 6.27

Open

$ 6.22

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 6.07 - $ 6.27

52 Week Range

$ 5.26 - $ 11.38

Volume

307,474

Average Volume

Market Cap

252.27M

Beta (5Y Monthly)

$ 0.82

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	04-09-2024	02-29-2024	10-Q
2	01-08-2024	11-30-2023	10-Q
3	10-05-2023	08-31-2023	10-Q
4	08-03-2023	05-31-2023	10-K
5	03-31-2023	02-28-2023	10-Q
6	01-06-2023	11-30-2022	10-Q
7	10-11-2022	08-31-2022	10-Q
8	07-22-2022	05-31-2022	10-K
9	04-07-2022	02-28-2022	10-Q
10	01-07-2022	11-30-2021	10-Q
11	09-30-2021	08-31-2021	10-Q
12	07-27-2021	05-31-2021	10-K
13	03-31-2021	02-28-2021	10-Q
14	01-08-2021	11-30-2020	10-Q
15	10-07-2020	08-31-2020	10-Q
16	08-10-2020	05-31-2020	10-K
17	04-08-2020	02-29-2020	10-Q
18	01-08-2020	11-30-2019	10-Q
19	10-04-2019	08-31-2019	10-Q
20	07-25-2019	05-31-2019	10-K
21	04-02-2019	02-28-2019	10-Q
22	01-07-2019	11-30-2018	10-Q
23	10-01-2018	08-31-2018	10-Q
24	07-23-2018	05-31-2018	10-K
25	04-05-2018	02-28-2018	10-Q
26	01-05-2018	11-30-2017	10-Q
27	09-29-2017	08-31-2017	10-Q
28	08-04-2017	05-31-2017	10-K
29	04-03-2017	02-28-2017	10-Q
30	01-06-2017	11-30-2016	10-Q
31	10-05-2016	08-31-2016	10-Q
32	08-01-2016	05-31-2016	10-K
33	04-11-2016	02-29-2016	10-Q
34	01-08-2016	11-30-2015	10-Q
35	10-08-2015	08-31-2015	10-Q
36	08-10-2015	05-31-2015	10-K
37	04-09-2015	02-28-2015	10-Q
38	01-09-2015	11-30-2014	10-Q
39	10-15-2014	08-31-2014	10-Q
40	08-14-2014	05-31-2014	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Insiders Buying Zumiez And 3 Other Stocks
04/09/2024 11:29:06

Although U.S. stocks closed little changed on Monday, there were a few notable insider trades.

Oppenheimer Upgrades AngioDynamics to Outp...
04/05/2024 12:40:31

Oppenheimer analyst Steven Lichtman upgrades AngioDynamics (NASDAQ:ANGO) from Perform to Outperform and announces $12 price ...

medical-devices-focused-angiodynamics-unveils-upbeat-2024-financial-outlook-stock-soars

Medical Devices Focused AngioDynamics Unve...
04/04/2024 16:53:06

FDA grants 510(k) clearance to AngioDynamics' AlphaVac F1885 System for pulmonary embolism. Expanded indication broadens tr...

CORRECTION: AngioDynamic Expects FY2024 Gr...
04/04/2024 16:13:57

Angiodynamic Expects FY2024 Sales Of $270M...
04/04/2024 11:06:18

AngioDynamics Q3 Adjusted EPS $(0.16) Miss...
04/04/2024 11:02:30

AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.1...

AngioDynamics Secures 510(k) Clearance For...
04/04/2024 10:46:30

The expanded FDA indication allows for the utilization of the AlphaVac F1885 System for the treatment of PE, which broadens the...

Earnings Scheduled For April 4, 2024
04/04/2024 09:18:17

Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on r...

angiodynamics-resolves-decade-long-patent-litigation-with-becton-dickinson-in-settlement-agreement

AngioDynamics Resolves Decade-Long Patent ...
04/02/2024 12:51:58

AngioDynamics resolves decade-long patent litigation with Becton, Dickinson in landmark settlement, streamlining legal expenses...

AngioDynamics Reports Settlement Of All Pa...
04/01/2024 21:32:12

Under the terms of the settlement, BD will grant a license to AngioDynamics under certain of BD's port patents and AngioDyn...

AngioDynamics Announces Sale Of PICC And M...
02/15/2024 21:30:51

Portfolio optimization enhances strategic focus and follows initiative to restructure manufacturing footprintCompany to discont...

AngioDynamics Announces FDA 510(k) Clearan...
01/23/2024 13:15:30

225-cm Catheter Length Expands Access Points in Atherectomy Procedures to Help Reduce Access Site Complications and Accelerate ...

Raymond James Maintains Outperform Rating ...
01/09/2024 17:00:25

Raymond James Maintains Outperform on Angi...
01/09/2024 10:07:42

Raymond James analyst Jayson Bedford maintains AngioDynamics (NASDAQ:ANGO) with a Outperform and lowers the price target fro...

Robinhood To Rally Around 18%? Here Are 10...
01/08/2024 12:42:01

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

HC Wainwright & Co. Maintains Buy on Angio...
01/08/2024 11:33:25

HC Wainwright & Co. analyst Yi Chen maintains AngioDynamics (NASDAQ:ANGO) with a Buy and lowers the price target from $2...

why-applied-therapeutics-shares-are-trading-lower-by-over-35-here-are-other-stocks-moving-in-fridays-mid-day-session

Why Applied Therapeutics Shares Are Tradin...
01/05/2024 18:13:57

Shares of Applied Therapeutics, Inc.

why-is-medical-devices-focused-angiodynamics-stock-trading-lower-today

Why Is Medical Devices-Focused AngioDynami...
01/05/2024 15:35:19

AngioDynamics Inc (NASDAQ: ANGO) has reported a second-quarter (Q2) FY24 adjusted EPS loss of $(0.05), compared to the consensu...

us-stocks-poised-to-extend-new-year-slump-as-focus-shifts-to-december-jobs-data-analyst-sees-sp-testing-4800-on-this-condition

US Stocks Poised To Extend New Year Slump ...
01/05/2024 12:36:42

Important metrics to track include the flow of individuals entering the labor force and the ratio of part-time workers to full-...

AngioDynamics Sees Adjusted EPS Loss Of $(...
01/05/2024 12:10:29